Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study

BACKGROUND: Cryopyrin-associated periodic syndrome (CAPS) is a rare disease. Knowledge on the quality of life (QoL) and the disease’s societal impact is limited. Canakinumab is used in increasing frequency for the treatment of CAPS. METHODS: Observational study in Dutch CAPS patients. Patients compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulders-Manders, Catharina M., Kanters, Tim A., van Daele, Paul L. A., Hoppenreijs, Esther, Legger, G. Elizabeth, van Laar, Jan A. M., Simon, Anna, Hakkaart-van Roijen, Leona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910566/
https://www.ncbi.nlm.nih.gov/pubmed/29678136
http://dx.doi.org/10.1186/s13023-018-0799-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910566/
https://www.ncbi.nlm.nih.gov/pubmed/29678136
http://dx.doi.org/10.1186/s13023-018-0799-1

Ejemplares similares